UPC: life sciences lead the momentum at new court
15-08-2023
Sanofi v Amgen antibody case lands front of queue at UPC
06-06-2023
UPC releases contingency plan for hard copy opt-outs
30-05-2023
LCV / Shutterstock.com
Revocation and infringement actions involving a cholesterol treatment, prosthetic valves, and methods for analyte detection are among the first to land at the court within its first month, explain Joanne Welch and Darren Smyth of EIP.
The Unified Patent Court’s (UPC) doors have been open since June 1. One month on, there is an opportunity to consider which parties have decided to dip their toes into the waters of the new court for their life sciences matters.
First up we have Sanofi/Regeneron and Amgen. These parties have previously locked horns in Germany in relation to Amgen’s EP2215124 and Regeneron’s Praluent cholesterol lowering medication.
Now at the UPC, Amgen has, on the first day, filed an infringement action in the Munich local division in relation to its EP3666797. This was only granted on May 17, 2023, titled “Antigen Binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)”, with the invention said to be useful for treating or preventing hypercholesterolemia.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
Cooley
European Patent Office
Finnegan LLP
GH Research
Gowling WLG
George Washington Law School
HGF Limited
IQVIA
Kirkland & Ellis International LLP
Marks & Clerk
Mintz Levin
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
Taylor Wessing
The United States Patent and Trademark Office (USPTO)
Valea AB
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at achoudhury@newtonmedia.co.
If you have any technical issues please email tech support.
patents, unified patent court, UPC, EPO, infringement, revocation, munich, Sanofi, Regeneron, Amgen, 10X Genomics, Vizgen, NanoString Technologies, astella
